1.
2.
Job titles of the future: Nature’s drug designer
(technologyreview.com)
3.
4.
How I use AI to turn failed drugs into new medicines
(feeds.nature.com)
5.
Is the peptide craze backed by science? The promise behind the hype
(feeds.nature.com)
6.
Ozempic May Be Reshaping the Brain, Scientists Say
(slashdot.org)
7.
What would you be willing to put in your body?
(theverge.com)
8.
Roids were all the rage at the Enhanced Games
(theverge.com)
9.
Could a pill prevent the world’s deadliest cancer?
(feeds.nature.com)
10.
11.
The ‘Steroid Olympics’ are happening this weekend, and even former Olympians are taking part
(feeds.feedburner.com)
12.
How we’re using AI tools to improve psychedelic-drug research
(feeds.nature.com)
13.
14.
15.
16.
A plan to make drugs in orbit is going commercial
(technologyreview.com)
17.
Are non-antibiotic drugs contributing to antimicrobial resistance?
(feeds.nature.com)
18.
20.
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease
(feeds.content.dowjones.io)
21.
22.
23.
RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban
(arstechnica.com)
24.
25.
26.
27.
Daily briefing: AI spread information about an obviously made-up disease
(feeds.nature.com)
28.
Why obesity drugs work better for some people: these genes hold clues
(feeds.nature.com)
29.
Genetics reveal why people respond differently to GLP-1 weight-loss drugs
(feeds.nature.com)
30.
Gilead to Buy German Biotech Tubulis for $3 Billion for Experimental Cancer Drugs
(feeds.content.dowjones.io)
Today's top topics:
anthropic
fable 5
mythos 5
us government
ai models
project glasswing
cybersecurity
claude
openai
mythos